Dr. Moore received his bachelor’s degree from Allegheny College and his MD from University of Pittsburgh School of Medicine. He is board-certified in internal medicine, medical oncology and hematology. After completing a postdoctoral fellowship at the Ohio State University, Dr. Moore joined the National Cancer Institute as a senior investigator in the Clinical Investigations Branch and later at the Investigational Drug Branch of the Cancer Therapy Evaluation Program (CTEP). During his 5 years at NCI, he was responsible for drug development for a number of agents including Topoisomerase I inhibitors. He was also the project officer for the preclinical chemotherapy combination project while at CTEP. After his tenure at NCI, he returned to Ohio to join a hematology/oncology private practice, which is very active in investigational trials.

Dr. Moore is an active member of American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH) as well as the American College of Physicians and the American Medical Association. Dr. Moore has also been the Director of Palliative Care Service at Grant Medical Center in Columbus, Ohio since 1996. Dr. Moore has more than 20 publications, many of which focus on Phase I-II trials of new agents as well as quality of life issues in cancer patients.